1Tashkin DP. Is a long-acting inhaled bronehodilator the first agent to use in stable chronic obstructive pulmonary disease?. Curr Opin Pulm Med,2005,11 : 121-128.
2Casaburi R, Conoscenti CS. Lung function improvements with once-daily tiotropium in chronic obstructive pulmonary disease. Am J Med,2004,117(Suppl 112A):33S-40S.
3Disse B,Speck GA, Rominger KL, et al. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. Life Sci, 1999,64: 457-464.
4Koumis T, Samuei S. Tiotropium bromide: a new long-acting bronehodilator for the treatment of chronic obstructive pulmonary disease. Clin Ther, 2005,27 : 377-392.
5Panning CA,DeBisschop M. Tiotropium: an inhaled, long acting anticholinergic drug for chronic obstructive pulmonary disease. Pharmacotherapy, 2003,23: 183-189.
6van Noord JA, Smeets JJ, Custers FL, et al. Pharmacodynamie steady state of tiotropium in patients with chronic obstructive pulmonary disease. Eur Respir J, 2002,19 : 639-644.
7Maesen FP, Smeets J J, Sledsens TJ, et al. Tiotropium bromide, a long-acting antimuscarinic bronchodilator : a pharmacodynamic study in patients with chronic obstructive pulmonary disease(COPD). Eur Respir J, 1995,8 : 1506-1513.
8Pieper MP, Chaudhary NI, Park JE. Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide. Life Sci,2007,80:2270-2273.
9Wettengel R. Neue Studie vergleicht Tiotropium and Salmeterol. Med Klin(Munich), 2001,15 (Suppl 2): 7-11.
10Casabud R, Briggs DD Jr, Donohue JF, et al. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD:a 13-week multieenter trial. The US Tiotropium Study Group. Chest, 2000,118 : 1294-1302.
